oct - 4 2003 KoRn SoS
510(K) SUMMARY

Common/Usual Name: Laser Instrument Fiber and Procedure Kit

Product Trade Name: Vari-Lase Endovenous Laser Procedure Kit

Classification Name: Laser Surgical Instrument for use in General and Plastic
Surgery and in Dermatology
21 CFR 878-4810 (Product Code GEX)

Manufacturer: Vascular Solutions, Inc.

6464 Sycamore Court
Minneapolis, Minnesota 55369

Establishment Registration: 2134812

Contact: / Deborah Jensen
V. P., Regulatory Affairs, Clinical Affairs, and Quality
Systems
(763) 656-4349 phone
(763) 656-4250 fax

Performance Standards: No performance standards have been developed under
section 514 for this device.

Device Description: The VARI-LASE procedure kit contains a 600p1m fiber and
may contain one ore more of the following accessories used
to gain endovascular access:

0.035’7/ stainless steel guide wire (lengths from 75 to
150cm)

5Fr/25, 45 or 55cm introducer sheath

19 Gauge/7cm Percutaneous Entry Needle or
Micropuncture Kit

Intended Use: The VARI-LASE procedure kit is indicated for the
treatment of varicose veins and varicosities associated with
superficial reflux of the Greater Saphenous Vein.

Summary of Non-Clinical Testing: No testing was requited to document the safety and
effectiveness of this modified procedure kit.

Predicate Devices: VARI-LASE Procedure Kit (K030654)

Conclusions: The VARI-LASE Procedure Kit is substantially equivalent
to the currently marketed VARI-LASE kit based on a
comparison of the indications for use and the components
supplied and the technological characteristics of the
supplied components.

P Le DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
“ty, a — TTT
mont Food and Drug Administration
9200 Corporate Boulevard
OCT - 1 2003 Rockville MD 20850
Ms. Deborah Jensen
Vice President, Regulatory Affairs.
Clinical Affairs, and Quality Systems
Vascular Solutions, Inc.
: 6464 Sycamore Court
Minneapolis, Minnesota 55369
Re: K032805
Trade/Device Name: Vascular Solutions Vari-Lase™ Endovenous Laser Procedure Kit
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in general and
plastic surgery and in dermatology
Regulatory Class: II
Product Code: GEX
Dated: September 8, 2003
Received: September 9, 2003
Dear Ms. Jensen:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed In interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug.
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class II (Special Controls) or class II] (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - Ms. Deborah Jensen
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled.
"Misbranding by reference to premarket nottfication” (21 CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www. fda.gov/cdrh/dsma/dsmamain. html

Sincerely yours,

Tuam 6 Prrrort

fC cstia M. Witten, Ph.D., M.D.
Director
Division of General, Restorative
and Neurological Devices

Office of Device Evaluation

Center for Devices and Radiological Health
Enclosure ~

Indications for Use Statement
sf
510(k) Number: KO BAG
Device Name: Vascular Solutions Vari-Lase™ Endovenous Laser Procedure Kit
Indications for Use:
The VARI-LASE procedure kit is indicated for the treatment of varicose veins and
varicosities associated with superficial reflux of the Greater Saphenous Vein.
1 VY,

Qivision Sign-Off) .

Division of General, Restorative

and Neurological Devices

510(k) Number__K 03 250S~

